We bring you the latest news from the healthcare about the health care in the United Kingdom.

woensdag 28 februari 2018

Latest content from npj Vaccines: 28 February 2018

If you are unable to see the message below, click here to view.
npj Vaccines

Advertisement
npj Vaccines is an online-only, open access, multidisciplinary journal dedicated to publishing cutting-edge research and development on human and veterinary vaccines. npj Vaccines is now open for submissions.
 
Explore the benefits of submitting your next manuscript to the journal.

Table of Contents: February 2018

Review Article | 27 February 2018

Prospects for strain-specific immunotherapy in Alzheimer’s disease and tauopathies

Alice Bittar, Urmi Sengupta & Rakez Kayed

npj Vaccines 3, Article number: 9 | doi:10.1038/s41541-018-0046-8

Comment | 12 February 2018

Obituary: Geoffrey Schild (1935–2017)

Philip Minor

npj Vaccines 3, Article number: 8 | doi:10.1038/s41541-018-0045-9

Article | 05 February 2018

Design and production of conjugate vaccines against S. Paratyphi A using an O-linked glycosylation system in vivo

Peng Sun, Chao Pan, Ming Zeng, Bo Liu, Haoyu Liang et al.

npj Vaccines 3, Article number: 4 | doi:10.1038/s41541-017-0037-1

Publisher Correction | 01 February 2018

Publisher Correction: A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus

Meihui Xu, Roland Zuest, Sumathy Velumani, Farhana Tukijan, Ying Xiu Toh et al.

npj Vaccines 3, Article number: 7 | doi:10.1038/s41541-018-0044-x

Review Article | 01 February 2018

Pregnancy and infection: using disease pathogenesis to inform vaccine strategy

Meghan S. Vermillion & Sabra L. Klein

npj Vaccines 3, Article number: 6 | doi:10.1038/s41541-017-0042-4

Your email address is in the npj Vaccines mailing list.
You have been sent this alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: myaccount (You will need to log in to be recognised as a nature.com registrant)
For further technical assistance, please contact our registration department
For print subscription enquiries, please contact our subscription department
For other enquiries, please contact our customer feedback department
Springer Nature | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA
Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.
© 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
Springer Nature